Literature DB >> 19732606

Aspirin resistance.

Udaya S Tantry1, Elisabeth Mahla, Paul A Gurbel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19732606     DOI： 10.1016/j.pcad.2009.05.001

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN： 0033-0620            Impact factor:   8.194


× No keyword cloud information.
  15 in total

1.  Aspirin treatment failure and the risk of recurrent stroke and death among patients with ischemic stroke.

Authors:  Alexandros L Georgiadis; Steve M Cordina; Gabriela Vazquez; Nauman Tariq; M Fareed K Suri; Kamakshi Lakshminarayan; Harold P Adams; Adnan I Qureshi
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-08-10       Impact factor: 2.136

Review 2.  Pharmacology of antiplatelet agents.

Authors:  Kiran Kalra; Christopher J Franzese; Martin G Gesheff; Eli I Lev; Shachi Pandya; Kevin P Bliden; Udaya S Tantry; Paul A Gurbel
Journal:  Curr Atheroscler Rep       Date:  2013-12       Impact factor: 5.113

Review 3.  The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Authors:  Yao Yang; Joshua P Lewis; Jean-Sébastien Hulot; Stuart A Scott
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-07-14       Impact factor: 4.481

4.  Design, synthesis and biological evaluation of hybrid nitroxide-based non-steroidal anti-inflammatory drugs.

Authors:  Komba Thomas; Terry W Moody; Robert T Jensen; Jason Tong; Cassie L Rayner; Nigel L Barnett; Kathryn E Fairfull-Smith; Lisa A Ridnour; David A Wink; Steven E Bottle
Journal:  Eur J Med Chem       Date:  2018-01-31       Impact factor: 6.514

5.  To stop or continue aspirin before aortocoronary bypass operations-do we have enough evidence to adequately guide us?

Authors:  Elisabeth Mahla; Udaya S Tantry; Paul A Gurbel
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 6.  Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis.

Authors:  Scot H Simpson; John-Michael Gamble; Laurie Mereu; Thane Chambers
Journal:  J Gen Intern Med       Date:  2011-06-07       Impact factor: 5.128

Review 7.  The pharmacogenetics of antiplatelet agents: towards personalized therapy?

Authors:  Tariq Ahmad; Deepak Voora; Richard C Becker
Journal:  Nat Rev Cardiol       Date:  2011-08-09       Impact factor: 32.419

8.  Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes.

Authors:  Joshua P Lewis; Kathleen Ryan; Jeffrey R O'Connell; Richard B Horenstein; Coleen M Damcott; Quince Gibson; Toni I Pollin; Braxton D Mitchell; Amber L Beitelshees; Ruth Pakzy; Keith Tanner; Afshin Parsa; Udaya S Tantry; Kevin P Bliden; Wendy S Post; Nauder Faraday; William Herzog; Yan Gong; Carl J Pepine; Julie A Johnson; Paul A Gurbel; Alan R Shuldiner
Journal:  Circ Cardiovasc Genet       Date:  2013-02-07

Review 9.  Cardiovascular safety of NSAIDs: Additional insights after PRECISION and point of view.

Authors:  Carl J Pepine; Paul A Gurbel
Journal:  Clin Cardiol       Date:  2017-12-16       Impact factor: 2.882

10.  Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention.

Authors:  Dániel Aradi; Robert F Storey; András Komócsi; Dietmar Trenk; Dietrich Gulba; Róbert Gábor Kiss; Steen Husted; Laurent Bonello; Dirk Sibbing; Jean-Philippe Collet; Kurt Huber
Journal:  Eur Heart J       Date:  2013-09-25       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.